Meige syndrome: relief on high-dose anticholinergic therapy.
A patient with Meige syndrome associated with spasmodic torticollis was treated with benztropine mesylate (Cogentin) at doses of 12-16 mg daily. Marked suppression of both oromandibular dystonia and the torticollis was obtained. Mild impairment of recent memory was the major side effect. Peripheral anticholinergic side effects were controlled by the concomitant administration of ambenonium chloride (Mytelase) 15 mg daily.
D000549:Ambenonium Chloride / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000188:drug therapy*; D001590:Benztropine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use*; D002230:Carbidopa / Q000627:therapeutic use; D006801:Humans; D010276:Parasympatholytics / Q000008:administration & dosage / Q000627:therapeutic use*; D014282:Trihexyphenidyl / Q000627:therapeutic use; D014326:Tropanes / Q000627:therapeutic use*
D010276:Parasympatholytics; D014326:Tropanes; D001590:Benztropine; D000549:Ambenonium Chloride; D014282:Trihexyphenidyl; D002230:Carbidopa